glp 1 rezeptor antagonist GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art The GLP-1 Agonists and Obesity:
Description
It has not yet been published in a peer-reviewed journal
There is evidence available to support the role of dietary supplementation across clinical trials in individuals with obesity, including weight loss interventions and adiposity-related complications
Some individuals, such as those with MTHFR gene variants, may benefit more from active forms like methylfolate
One review found that Lactobacillus and Bifidobacterium are bacterial probiotics that promote GLP-1
[DOI] [PubMed] [Google Scholar] 39.Killion EA, et al
